Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels. by Sawada, Takeshi et al.
Title Diagnosis of moyamoya disease using 3-T MRI and MRA:value of cisternal moyamoya vessels.
Author(s)
Sawada, Takeshi; Yamamoto, Akira; Miki, Yukio; Kikuta,
Ken-Ichiro; Okada, Tomohisa; Kanagaki, Mitsunori; Kasahara,
Seiko; Miyamoto, Susumu; Takahashi, Jun C; Fukuyama,
Hidenao; Togashi, Kaori
CitationNeuroradiology (2012), 54(10): 1089-1097
Issue Date2012-10
URL http://hdl.handle.net/2433/162004





Diagnosis of moyamoya disease using 3T MRI 
and MRA:  
Value of cisternal moyamoya vessels 
 
Takeshi Sawada, MD1), Akira Yamamoto, MD, PhD1), Yukio Miki, MD, PhD2), 
Ken-ichiro Kikuta, MD, PhD3), Tomohisa Okada, MD, PhD1),  
Mitsunori Kanagaki, MD, PhD1), Seiko Kasahara, MD, PhD1),  
Susumu Miyamoto, MD, PhD4), Jun C. Takahashi, MD, PhD4),  
Hidenao Fukuyama, MD, PhD5), Kaori Togashi, MD, PhD1) 
 
1. Department of Diagnostic Imaging and Nuclear Medicine, Kyoto 
University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, 
Kyoto, 606-8507, Japan 
2. Department of Radiology, Osaka City University Graduate School of 
Medicine 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan 
3. Division of Sensory and Locomotor Medicine, Factory of Medical Sciences, 
University of Fukui, 23-3, Matsuokashimoaizuki, eiheiji-cho, Yoshida-gun, Fukui 
910-1193, Japan 
4. Department of Neurosurgery, Kyoto University Graduate School of 
Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan 
5. Human Brain Research Center, Kyoto University Graduate School of 




















Introduction The purpose of this study was to propose a new MR criteria of 
diagnosing MMD from cisternal MMVs on 3T MRI/MRA and compare the diagnostic 
accuracy of the existing MR criteria and the proposed MR criteria. 
Methods Participants comprised 20 consecutive patients with MMD (4 males, 
16 females) diagnosed clinically using conventional angiography, and 20 controls (13 
male and 7 female arteriosclerosis patients). In these participants, 3T MRI/MRA was 
evaluated by the existing MR criteria, which use MMVs in basal ganglia and the 
proposed MR criteria, which use cisternal MMVs, then these two criteria were 
statistically compared by McNemar’s test. 
Results Diagnostic accuracy was 62.5% with the existing MR criteria and 
97.5% with the proposed MR criteria. The proposed MR criteria was more sensitive 
(1.00) than the existing MR criteria (0.45), but less specific (0.95) than the existing 
MR criteria (1.00). 
Conclusion  The proposed MR criteria using cisternal MMVs showed significantly 
higher diagnostic accuracy than the existing MR criteria. We believe that our 
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ACA anterior cerebral artery 
AUC area under the curve 
CSF cerebrospinal fluid 
FSE fast spin echo  
ICA internal carotid artery  
MCA middle cerebral artery  
MIP maximum intensity projection 
MMD moyamoya disease 
MMVs moyamoya vessels 
MR magnetic resonance  
MRA magnetic resonance angiography 
MRI magnetic resonance imaging 
ROC receiver operating characteristic 
SNR signal-to-noise ratio 
SWI susceptibility-weighted imaging 






MMD is a relatively rare disorder in which distal portions of the ICAs and/or 
proximal portions of the ACA and/or MCA become progressively steno-occlusive 
with secondary formation of collateral vessels and abnormal vascular network 
called MMVs[1]. This disease occurs predominantly in Japanese, but occurrence 
has also been reported in other countries[2-3]. The etiology of MMD has been 
unknown for long, but recently its responsible genes are being identified[4]. There 
are reported links between moyamoya-like state and a wide variety of other 
disorders such as radiation arteritis, Down’s syndrome and so on, they are 
excluded clinically[5]. By the finding of conventional angiography, disease 
severity is frequently classified into one of six progressive stage (Suzuki’s 
stage)[1]. MMD is well known to cause transient ischemic attacks, cerebral 
infarction, or intracranial bleeding in both children and adults[6-7]. Intracranial 
bleeding, in particular, often results in poor outcomes[1]. Cases with relatively 
mild and slow progression are usually treated more conservatively, while cases 
with faster progression are treated surgically, such as with vascular bypass 
methods[2]. Treatment of MMD depends on the possibility of faster deterioration, 
so frequent follow-up imaging as well as accurate diagnosis and staging of the 
disease on each examination is indispensable in the clinical situation. 
MMD has been diagnosed using diagnostic criteria that apply results 
from conventional angiography and MRI/MRA independently[5]. In the existing 
guideline, conventional angiography still remains to be the gold standard for the 
diagnosis of MMD in principle[8-9], and the relatively large number of patients 
that do not fulfill the diagnostic criteria from MRI/MRA need diagnostic 
conventional angiography[5,10-11]. Conventional angiography can visualize 
stenosis of both normal and MMVs more clearly and definitively, therefore 
enabling more precise evaluation of vessels, which is necessary for surgical 
treatment. One drawback of the existing diagnostic criteria using conventional 
angiography is the possibility of unwanted side effects such as contrast media 
allergy which might be serious in some cases[12]. Another drawback of the 
existing diagnostic criteria is the technical difficulty of conventional angiography 
in pediatric cases due to the narrow artery and need for sedation. 
Nowadays, 3T MR is widely used in clinical situations and has been 
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reported to show superiority to 1.0/1.5T MR in the diagnosis of various 
neurological disorders [13-15]. The higher spatial resolution and SNR of 3T MR 
are useful for evaluating the fine features of MMD. MMVs have been reported to 
be better delineated with MRA at 3T than at 1.5T[15]. For microbleeds in MMD, 
representing an important factor for prognosis[16], SWI has been reported to offer 
better detection at 3T than 1.5T MRI[17]. In the clinical situation, MRI/MRA 
findings have been used for diagnosis of MMD, such as cisternal MMV and the 
FLAIR ivy sign [18-19]. Among these fine features of MMD, the cisternal MMVs 
visualized as a distinct feature of MMD on 3T MR might be beneficial for 
diagnosing MMD. These fine features of MMD visualized by recent MR 
technique have been available by now, therefore an updated guideline which 
reflects these benefits has been needed. This study proposes a new diagnostic 
criteria for MMD using cisternal MMVs evaluated by routine clinical 3T 
MRI/MRA. We hypothesized that the proposed MR diagnostic criteria using 3T 
MR can diagnose MMD more accurately by evaluating cisternal MMVs than the 
existing MR criteria, which evaluates MMVs in the basal ganglia. The purpose of 
this study was to evaluate the diagnostic accuracy of the proposed MR criteria and 




MATERIALS AND METHODS 
Patients 
All study protocols were approved by the local ethics committee and written 
informed consent was obtained from all patients or their parents. The study 
included 20 consecutive patients with MMD from March 2004 to April 2008 (4 
male, 16 female; mean age 26.3 years; range, 2-58 years) and 20 controls (13 male 
and 7 female arteriosclerosis patients; mean age, 64.7 years; range, 27-87 years). 
All MMD patients had been diagnosed clinically using the existing diagnostic 
criteria, including conventional angiography. Suzuki’s stages of MMD patients 
are shown in Table 1. Cases of unilateral MMD were not included in this study. 
Control arteriosclerosis patients showed multi-vessel stenosis. Four cases showed 
3 vessel stenoses, 8 cases showed 2 vessel stenoses, and 8 cases showed stenosis 
of 1 vessel. 
 
Image acquisition 
All patients and controls underwent 3D TOF MRA and FSE T2WI using a 3T MR 
scanner (Magnetom Trio; Siemens, Erlangen, Germany). A dedicated head array 
coil was used for image acquisition. The following parameters were used for TOF 
MRA: repetition time, 22 ms; echo time, 3.7 ms; flip angle, 20°; slice thickness, 
0.7 mm; slab thickness, 33.6mm; number of slabs, 3; field of view, 200 × 150 
mm; matrix, 320 × 240; voxel size, 0.625 × 0.625 × 0.7 mm; and acquisition time, 
5 min 51 s. The following parameters were used for FSE T2WI: repetition time, 
3200 ms; echo time, 79 ms; echo trains per slice, 14; slice thickness, 3 mm; slice 
gap, 1mm; field of view, 220 × 176 mm; matrix, 448 × 360; voxel size, 0.6 × 0.5 
× 3 mm; and acquisition time, 1 min 44 sec. 
 
Diagnostic methods 
The existing MR criteria for diagnosis of MMD using MRI/MRA[5] and the 
proposed MR criteria for diagnosis of MMD using 3T MRI/MRA are shown in 
Table 2, Fig. 1 and 2. 
In Sylvian valley, T2WI shows cisternal MMVs as worm-like structures 
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and a network of numerous randomly formed flow voids in axial slices (Fig. 3). 
Source images from TOF MRA also show MMVs as a network of numerous 
randomly formed high signal intensity structures in the cisternal low signal 
intensity (Fig. 4). In this study, cisternal MMVs were evaluated on T2WI and 
TOF MRA with source images. 
 
Image evaluation 
Two board-certified neuroradiologists (T.S. and A.Y. over 8 years experience) 
evaluated T2WI and TOF MRA using the existing and proposed MR criteria. 
Evaluation based on MRI/MRA for each side was classified into 5 categories (5, 
absolutely positive; 4, probably positive; 3, unclear; 2, probably negative; and 1, 
absolutely negative). 
The procedure for evaluation using the existing MR criteria is as follows: 
a) evaluation of whether stenosis exists at the ICA and/or ACA, and/or MCA on 
the right side; b) evaluation of MMVs in the basal ganglia on T2WI(Fig. 2) on the 
right side; and c) repetition of the same evaluations for the left side.  
The procedure for evaluation using the proposed MR criteria is as 
follows: a) evaluation of whether stenosis exists at the ICA and/or ACA, and/or 
MCA on the right side; b) evaluation of MMVs in Sylvian valley(Fig. 3,4) on the 
right side; and c) repetition of the same evaluation on the left side. 
In this study, evaluation was performed on the right and left sides 
separately, because the degree of stenosis of arteries and formation of MMVs are 
not symmetrical in all MMD patients[20]. In the existing MR criteria and the 
proposed MR criteria, the concordance rate of the scores by the two 
neuroradiologists was evaluated by the Kappa coefficient. If the scores for each 
side did not fully agree, the scores were decided by consensus. The diagnostic 
category for the patient was defined as the average of category scores of the left 
and right sides. Sample images of a MMD patient are shown in Fig. 5. The 
diagnostic category by the existing MR criteria was 1, and that by the proposed 





As the first analysis, ROC curves for both the existing and proposed MR criteria 
were used for statistical evaluation of diagnostic accuracy. AUC for each criteria 
was then calculated and comparisons of diagnostic accuracy for the existing and 
proposed MR criteria were performed using Hanlay’s method, with values of 
p<0.05 considered significant[21]. 
As the second analysis, cut-off points were calculated for each criteria to 
maximize sensitivity and specificity. Using these cut-off points for each criteria, 
diagnostic accuracies of the two criteria for clinical diagnosis were calculated 
according to results from conventional angiography and compared using 
McNemar’s test[22]. 
As the third analysis, to avoid calculation bias from comparing two 
criteria with separate cut-off points, a common cut-off point was determined at the 
median of the range (category 3). Categories <3 were considered as not MMD and 
categories 3 as MMD, with category 3 included in MMD to maximize the 
sensitivity of the diagnostic method. With this common cut-off point, diagnostic 
accuracies of two criteria for clinical diagnosis using conventional angiography 




The Kappa coefficient of the scores of the two neuroradiologists by the existing 
MR criteria was 0.63, and that by the proposed criteria was 0.89. ROC curves for 
the two criteria are shown in Fig. 6. The diagnostic categories for MMD patients 
and controls are shown in Table 1. Standard deviations for the existing MR criteria 
were 0.71 in MMD patients and 0 in controls, and those for the proposed MR 
criteria were 0.26 in MMD patients and 1.16 in controls. Median values for the 
existing MR criteria were 1 in MMD cases and 1 in controls, and those for the 
proposed MR criteria were 5 in MMD patients and 1 in controls. 
AUC of the existing MR criteria was 0.725 (two-sided 95% confidence 
interval: 0.567-0.883). AUC of the proposed MR criteria was 0.999 (two-sided 
95% confidence interval: 0.988-1.000). A comparative test using Hanlay’s method 
showed the difference of two AUCs was 0.274, with a standard error of 0.080, and 
a correlation coefficient between the two AUCs of 3.403. A significant difference 
between the two criteria was identified (p = 0.0007). 
In the second analysis, cut-off points were calculated for each criteria to 
maximize sensitivity and specificity using ROC curves. The cut-off point for the 
existing MR criteria was 1.5 (sensitivity, 0.45; specificity, 1.00), compared to 3.25 
(sensitivity, 1.00; specificity, 0.95) for the proposed MR criteria. Using 
conventional angiography as the gold standard, accuracies of the two criteria with 
each cut-off point were 72.5% for the existing MR criteria and 97.5% for the 
proposed MR criteria. McNemar’s test showed a significant difference between 
the two criteria (p = 0.006). 
In the third analysis, the cut-off point for the existing and proposed MR 
criteria was the common cut-off point 3. Using conventional angiography as the 
gold standard, accuracies of the two criteria with the common cut-off point were 
62.5% for the existing MR criteria and 97.5% for the proposed MR criteria. 
McNemar’s test showed a significant difference between the two criteria 
(p=0.001).  




This study evaluated 3T MRI/MRA in 20 MMD patients and 20 controls using the 
existing and proposed MR criteria for diagnosis of MMD. AUC of ROC curves 
for these two criteria showed a significant difference. Accuracies of the existing 
and proposed MR criteria showed a significant difference according to 
McNemar’s test using each cut-off point and common cut-off point. The proposed 
MR criteria using 3T MRI/MRA showed superior diagnostic accuracy for MMD. 
The existing diagnostic criteria of MMD were defined by the Research 
Committee on Spontaneous Occlusions of the Circle of Willis (MMD) of the 
Ministry of Health and Welfare of Japan in 1997[5]. At that time, 1.0T or 1.5T 
MR were widely used and 3T MR were not widely available in clinical situations. 
In the evaluation of MMD patients, features of vessels delineated by MRI/MRA 
using 1.0/1.5T MR might be suboptimal for definitive diagnosis in more than a 
few cases[11]. Substantial cases were unable to be diagnosed using MRI/MRA 
alone, so conventional angiography has been required as the gold standard for 
definite diagnosis of MMD in not a few patients, including pediatric cases[23]. 
If the definite standard with high accuracy of diagnosis using the 
relatively less-invasive MR had settled, more patients could skip conventional 
angiography. This would prove beneficial for MMD patients, particularly for 
children. Several studies have discussed the diagnosis of MMD using MRI/MRA, 
mainly using 1.5T MR[11,24-27]. Although 1.5T MR can be used for diagnosing 
MMD in the clinical setting, the accuracy of diagnosis has been suboptimal due to 
the intrinsic difficulties of acquiring higher spatial resolution and higher SNR[28]. 
In many cases, conventional angiography has been used as the gold standard for 
clinical diagnosis of MMD under the existing diagnostic criteria[8-10]. 
Cisternal MMVs, one of the fine features of MMD, are defined as 
tortuous small vessels in Sylvian valley other than the MCA and its perforators 
and are visualized as worm-like structures on axial slices in MRI/MRA[18,29] 
(Fig.  3,4). These cisternal MMVs have been visualized using high-resolution 
T2WI with constructive interference in steady state imaging on 1.5T systems and 
may be beneficial in diagnosing MMD using MRI[30]. However, this 
sophisticated technique requires a relatively long scan time, and has thus been 
difficult to use in screening and frequent follow-up examinations. 
Nowadays, 3T MR has been introduced widely into clinical situations. 
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Various features of MMD have been reported to be more clearly apparent with 3T 
MR than with 1.5T MR, including vascular abnormalities on MRA and 
microbleeds on SWI[15,17]. Some reports have noted that 3T MRI/MRA 
visualizes more fine features of MMVs than MRI/MRA at 1.0/1.5T[14-15]. As 3T 
MRI offers a higher SNR than 1.0/1.5T MR, a higher spatial resolution on T2WI 
can be achieved. Also, 3T MR have a longer longitudinal relaxation time than 
1.0/1.5T MR, allowing improved T1 contrast and a higher signal on TOF MRA. 
These superior properties of 3T MRI/MRA might have performed a significant 
role in improving the accuracy of diagnosing MMD in this study. 
With the existing MR criteria, MMV is evaluated as flow voids in the 
basal ganglia on T2WI. On routine clinical 3T MR images, flow voids in the basal 
ganglia may be difficult to detect. Compared to 1.5T MRI, the basal ganglia 
sometimes show as areas of low signal intensity on 3T MRI due to the rich iron 
content[31], so low signal flow voids might be difficult to detect in the basal 
ganglia. Conversely, with the proposed MR criteria, MMVs were steadily 
evaluated in Sylvian valley, where low-signal vascular flow voids are more 
readily apparent against the background of high signal intensity CSF on T2WI 
[29]. In addition, 3T MRA showed MMVs more clearly in both the basal ganglia 
and Sylvian valley, due to the longer longitudinal relaxation time[15]. In the 
present study, T2WI and MRA were evaluated together in both the existing and 
proposed MR criteria, which may prevent influences of artifacts such as CSF flow 
void in Sylvian valley complementarily and facilitate evaluation of fine features 
of MMVs in the proposed MR criteria. 
If MMD can be definitively diagnosed using only 3T MRI/MRA, 
conventional angiography can be skipped. This may be beneficial for the first 
diagnosis of MMD, as the procedure for conventional angiography can have 
unwanted side effects[12]. In addition, this may be beneficial for patients with 
slow progression, who can be followed up using MRI/MRA alone and treated 
conservatively without surgical therapy unless frequent imaging examinations 
show deterioration [32]. Diagnosis of MMD using 3T MRI/MRA alone may thus 
be beneficial for accurate first diagnosis and subsequent imaging follow-ups for 
early treatment[33-34]. 
Several limitations must be considered when interpreting the results of 
this study. First, age-matched controls were not enrolled in the study. This is 
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because MMD patients in this study were younger than the control patients with 
arteriosclerosis. The incidence of MMD shows peaks in two age groups: children 
at approximately 5 years old and adults in their mid-40s[3,35]. Second, we used 
cisternal MMVs in Sylvian valley for diagnosis, but MMVs do not become 
obvious at stage 1, and vanish at stage 5-6[1]. The proposed MR criteria may not 
work in such low stage and higher-stage cases. Suzuki’s stages 1 and 2 are 
considered as the early stages of MMD. Stages 3 and 4, which are the most 
frequently observed stages, are clinically important and have to be clinically 
discriminated. Suzuki’s stages 5 and 6 are considered as the final stages of 
MMD[1,35]. And onset of the disease at stage 5 or 6 is rare, so evaluation of 
cisternal MMVs may be feasible in many cases. Diagnosis of stage 1 cases by 




This study evaluated the accuracy of the proposed MR criteria for diagnosing 
MMD using cisternal MMVs visualized by 3T MRI/MRA. The diagnostic 
accuracy of the proposed MR criteria was higher than that of the existing MR 
criteria. We believe that the proposed MR criteria using 3T MRI/MRA will prove 
beneficial for diagnosing MMD. 
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Fig. 1: MRA MIP of MMD showing stenosis of bilateral ICAs.  
Fig. 2: Axial FSE T2WI shows MMVs at the level of the basal ganglia. Flow voids 
indicating abnormal vascular networks are visualized at bilateral putamina. 
Fig. 3: Axial FSE T2WI shows MMVs at the level of Sylvian valley. Flow voids of 
MMVs were apparent in bilateral Sylvian valleys.  
Fig. 4: MRA source image also shows MMVs at the level of Sylvian valley. MMVs 
were apparent in bilateral Sylvian valleys as high signal intensity. 
Fig. 5: MRA MIP, T2WI and MRA source images from a patient with MMD (category 
5 by the proposed MR criteria; category 1 by the existing MR criteria). a) MRA MIP. 
b) T2WI at the level of Sylvian valley . c) T2WI at the level of the basal ganglia. d) 
MRA source image at the level of Sylvian valley. e) MRA source image at the level of 
the basal ganglia. 




Table 1: The diagnostic category of MMD patients and controls 






Age, Sex Diagnosis Category Category Rt. Lt. 
02Y, F MMD 4 5 4 4 
06Y, F MMD 3 5 3 4 
06Y, F MMD 2.5 4.5 3 2 
07Y, F MMD 2 5 2 3 
08Y, F MMD 3 5 2 4 
08Y, M MMD 5 5 4 4 
13Y, F MMD 1 5 2 3 
14Y, F MMD 1 5 2 2 
21Y, F MMD 1 4.5 2 2 
21Y, F MMD 2.5 5 4 4 
22Y, F MMD 1 5 4 4 
31Y, F MMD 2 5 3 3 
32Y, F MMD 1 5 3 2 
35Y, F MMD 1 4 2 2 
47Y, F MMD 3 5 3 3 
48Y, F MMD 1 5 4 3 
49Y, F MMD 1 5 3 3 
49Y, M MMD 1 4.5 2 2 
50Y, M MMD 1 5 3 3 
58Y, M MMD 1 5 3 3 
27Y, M CTR 1 4   
30Y, M CTR 1 1   
41Y, F CTR 1 1   
42Y, F CTR 1 1   
61Y, F CTR 1 1   
65Y, M CTR 1 1   
66Y, M CTR 1 1   
66Y, M CTR 1 1   
66Y, M CTR 1 1   
69Y, F CTR 1 1   
70Y, F CTR 1 1   
73Y, M CTR 1 1   
74Y, M CTR 1 1   
74Y, F CTR 1 1   
76Y, M CTR 1 2.5   
76Y, M CTR 1 1   
76Y, F CTR 1 1   
77Y, M CTR 1 1   
78Y, M CTR 1 1   
87Y, M CTR 1 1   
MMD = moyamoya disease, CTR = control 
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Table 2: The existing and proposed MR criteria for diagnosing MMD 
The existing MR criteria[5] 
When MRI and MRA clearly demonstrate all the below findings, conventional 
cerebral angiography is not mandatory. 
1. Stenosis or occlusion at the terminal portion of the ICA and/or at the proximal 
portion of the ACA and/or the MCA(Fig. 1). 
2. An abnormal vascular network in the basal ganglia on MRA. An abnormal 
vascular network can be diagnosed when more than two flow voids are seen on 
one side of the basal ganglia on MRI(Fig. 2). 
3. Bilateral appearance of (1) and (2). 
 
The proposed MR criteria 
1. Stenosis or occlusion at the terminal portion of the ICA and/or at the proximal 
portion of the ACA and/or the MCA. (Fig. 1). 
2. An abnormal vascular network of cisternal MMVs apparent in bilateral Sylvian 
valleys on T2WI or MRA(Fig. 3,4). 
3. Bilateral appearance of (1) and (2). 
  
20 
Table 3: The results of the second and third analysis 
 
 
 cut-off point Sensitivity Specificity Accuracy 
Second analysis Existing MR criteria 1.5 0.45 1.00 72.5% 
Proposed MR criteria 3.25 1.00 0.95 97.5% 
Third analysis 
 
Existing MR criteria 3  62.5% 
Proposed MR criteria 97.5% 






